Publication | Closed Access
Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis
13
Citations
0
References
2021
Year
This post-hoc analysis suggested that metformin might be an adjuvant therapy in achieving treat-to-target in SLE patients.